Evidence map›Paper›PMID 28839082›Full record

ArticleAntimicrobial agents and chemotherapy2017

Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?

Samuel L Aitken, Farnaz Foolad, Patrick M McDaneld

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Samuel L AitkenDivision of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA slaitken@mdanderson.org.
Farnaz FooladDivision of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Patrick M McDaneldDivision of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EnterobacteriaceaePiperacillinAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesEnterobacteriaceae InfectionsMicrobial Sensitivity TestsPenicillanic AcidTazobactamAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesPenicillanic AcidPiperacillinTazobactamantimicrobial stewardshipbacteremiacefepimeEnterobactermeropenem

Identifiers

PMID28839082
PMCPMC5571301
OpenAlexW2750125886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.